Menu

利伐沙班可治疗哪些疾病?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

It is a highly selective oral drug that directly inhibits factor Xa. By inhibiting factor

Indications for Rivaroxaban:

1. For adult patients undergoing elective hip or knee replacement surgery to prevent venous thrombosis (VTE).

2. Used to treat venous thrombosis (DVT) in adults and reduce the risk of DVT recurrence and pulmonary embolism (PE) after acute DVT.

3. For use in adult patients with non-valvular atrial fibrillation who have one or more risk factors (such as congestive heart failure, hypertension, age ≥75 years, diabetes, history of stroke or transient ischemic attack) to reduce the risk of stroke and systemic embolism.

Rivaroxaban usage and dosage:

Orally, 10 mg of rivaroxaban a day can be taken with food or alone. Rivaroxaban 15 mg or 20 mg tablets should be taken with food. When used to prevent venous thrombosis in adult patients undergoing elective hip or knee replacement surgery, the recommended dose of rivaroxaban is 10 mg orally once daily. If the wound has stopped bleeding, the first dose of medication should be between 6 and 10 hours after surgery.

The recommended dose of rivaroxaban tablets for the initial treatment of acute venous thrombosis is 15 mg twice daily for the first three weeks, followed by 20 mg once daily for maintenance treatment and to reduce the risk of recurrent venous thrombosis and pulmonary embolism.

Can special groups of people take rivaroxaban?

(1) Pregnant and lactating women: Disabled.

(2) Children: Not recommended for use by children under 18 years old.

(3) Elderly: Patients over 75 years old should reduce the dosage appropriately and please use it under the guidance of a physician or pharmacist.

(4) Hepatic insufficiency: It is contraindicated in patients with liver disease who have coagulation abnormalities and clinically relevant bleeding risks, including patients with decompensated cirrhosis.

(5) Renal insufficiency: It is contraindicated in patients with severe renal insufficiency. Other patients should have their renal function monitored regularly during treatment.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。